Table 4.
Variables | Group | Baseline | 1st week | 2nd week | 3rd week | 4th week |
---|---|---|---|---|---|---|
Dose (mg) (mention values as mean±SD) | Baclofen | - | 20±0.0 | 23.04±6.641 | 23.91±6.593 | 23.81±6.890 |
Topiramate | - | 25±0.0 | 50±0.0 | 120±25.162 | 125±35.355 | |
OCD (O) | Baclofen | 13.24±2.654 | 9.96±3.994@ | 6.64±4.156∞ | 3.52±4.155€ | 1.19±3.501© |
Topiramate | 14.0±3.628 | 13.04±3.702* | 10.08±4.319*,∞ | 8.27±4.783*,€ | 4.05±4.892*,© | |
OCD (C) | Baclofen | 13.28±2.913 | 7.76±5.789@ | 2.56±5.007∞ | 1.95±4.324€ | 0.81±3.709© |
Topiramate | 14.36±3.321 | 13.04±3.948* | 9.36±5.724**,∞ | 6.52±6.816**,€ | 2.77±5.275*,© | |
OCD (T) | Baclofen | 26.52±5.581 | 16.64±10.123@ | 9.21±7.942∞ | 5.48±7.983€ | 2.0±7.036© |
Topiramate | 28.36±6.769 | 26.08±7.410* | 19.44±9.747**,∞ | 14.5±11.359**,€ | 6.83±9.855*,© | |
VAS | Baclofen | 81.2±8.817 | 63.2±17.072@ | 39.56±14.924∞ | 24.78±23.906€ | 6.19±18.568© |
Topiramate | 82.4±10.116 | 78±11.547* | 65.2±17.823*,∞ | 48.63±26.603*,€ | 25.56±28.122*,© | |
Average drinking days/past week | Baclofen | 6.72±0.791 | 2.36±2.721@ | 0.782±1.730∞ | 0.434±1.502€ | 0.428±1.535© |
Topiramate | 6.44±1.044 | 5.12±1.833* | 3.32±2.495∞ | 2.22±2.810€ | 1.00±2.143© | |
Average number of drinks | Baclofen | 10.16±0.862 | 4.10±2.030@ | 2.356±1.466∞ | 1.356±1.160€ | 0.871±1.434© |
Topiramate | 11.92±0.959 | 6.40±0.931* | 4.96±1.262∞ | 3.045±1.565€ | 1.471±1.395© |
*Significant difference between baclofen and topiramate (0.05), **Significant difference between baclofen and topiramate (0.001), @Significant difference between baseline and 1st week assessment, ∞Significant difference between baseline and 2nd week assessment, €Significant difference between baseline and 3rd week assessment, ©Significant difference between baseline and 4th week assessment. OCD – Obsessive and compulsive drinking; SD – Standard deviation; VAS – Visual Analog Scale